Conrad Fischer highlights dalbavancin as a long-acting vancomycin alternative, claiming one dose can cover two weeks and two doses can cover eight weeks, including for bacteremia.
Dalbavancin
Long-Acting version of vancomycin
One dose= 2 weeks of vancomycin
Two doses (a week apart) = 8 weeks of vancomycin
Good for bacteremia as well
This finding is one of many signals tracked across Healthcare. The live feed updates every few hours with new authority voices, debates, and emerging ideas.
← Back to Healthcare